|
2021
|
Invention
|
Pharmaceutical compounds.
The invention provides a compound for use in the treatment of T-Cell A... |
|
|
Invention
|
Crystalline forms of a tyk2 inhibitor.
The invention provides crystalline forms of a compound ha... |
|
|
Invention
|
Crystalline forms of a tyk2 inhibitor. The invention provides crystalline forms of a compound hav... |
|
2020
|
Invention
|
Pharmaceutical compounds. The invention provides a method of inhibiting a TYK2 kinase, which meth... |
|
2019
|
Invention
|
Tyk2 kinase inhibitors. The invention provides compounds of the formula (1):
1 is hydrogen or fl... |
|
|
Invention
|
Tyk2 kinase inhibitors. The invention provides compounds of the formula (1): (1) or a salt or tau... |
|
2017
|
Invention
|
Pharmaceutical compounds. The invention provides a compound for use in the treatment of T-Cell Ac... |
|
2014
|
Invention
|
Oxazole tyrosine kinase inhibitors. 2 are as defined in the claims. The compounds are inhibitors ... |
|
2013
|
Invention
|
Pharmaceutical compounds. The invention provides a compound which is an amide of the formula (2):... |
|
|
Invention
|
Pharmaceutical compounds.
The invention provides a method of inhibiting a TYK2 kinase, which met... |
|
|
Invention
|
Aurora and flt3 kinases modulators. The invention provides a compound having the formula (1):
4 ... |
|
|
Invention
|
Aurora and flt3 kinases modulators. The invention provides a compound having the formula (1) usef... |
|
2012
|
Invention
|
Oxazole tyrosine kinase inhibitors.
The invention provides a compound which is an amide of the f... |
|
2009
|
Invention
|
Oxazole or imidazole derivatives for use in the treatment of autoimmune disesases, in particular ... |
|
2008
|
Invention
|
Oxazole tyrosine kinase inhibitors. The invention provides a compound which is an amide of the fo... |
